Streamlining Stem Cell Manufacturing
The Factory System Will Help the Stem Cell Industry Standardize, Integrate, and Automate Unit Operations
More Tooth, More Tail in CRISPR Operations
The Most Interesting Thing about CRISPR/Cas9 Is What It Can Accomplish in the Hands of Gifted Researchers
DNA: Past to Present 2017
Celebrate National DNA Day with a Look at Some of the Double-Helix’s Scientific History
Predict Drug Toxicity without Guesswork
Consider Organs-On-Chips, Pathway Simulations, and Transgenic Mice
For full access to this article login to GEN Select now.
U.S. Stem Cell Firms Partnering Overseas
Companies Find It Easier to Navigate Regulatory Requirements in Asia and Europe
- American companies focused on stem cell treatments and technology platforms have met with success in finding partnerships and revenues overseas in the past decade. And it’s not for the reason many people might think, namely the controversy over U.S. federal funding of human embryonic stem cell (hESC) research. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.